Rxwire
Trials & R&D · first seen 2h ago, updated 2h ago

Directors’ Deals: AstraZeneca’s Soriot in a major show of faith

1 outlet AstraZeneca

Share price is down after a series of disappointing drug trials

Summary from Financial Times - Pharmaceuticals.

Coverage 1 article · 1 outlet

  1. Financial Times - Pharmaceuticals
    Directors’ Deals: AstraZeneca’s Soriot in a major show of faith